Geron Corp. (GERN)

1.36 -0.03 (-2.16%) USD  |  NASDAQ  |  Dec 12, 16:00
1.34 -0.02 (-1.47%) After-Hours: 20:00
More

Geron Research and Development Expense (Quarterly): 21.07M for Sept. 30, 2025

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for GERN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Cassava Sciences, Inc. 3.955M
SELLAS Life Sciences Group, Inc. 4.216M
Rezolute, Inc. 13.15M
GT Biopharma, Inc. 0.634M
Ultragenyx Pharmaceutical, Inc. 207.61M